NCT00579761 is a clinical trial in Endocarditis, sponsored by Virginia Commonwealth University.

Who is sponsoring NCT00579761?

NCT00579761 is sponsored by Virginia Commonwealth University.

What condition does NCT00579761 study?

NCT00579761 studies Endocarditis.

Is NCT00579761 still recruiting?

NCT00579761 is currently withdrawn. Last updated 14 December 2015.

Last reviewed 2015-12-14 · How we verify

NCT00579761

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Retrospective Review of Management of Infective Endocarditis

Withdrawn Last updated 14 December 2015

What this trial tests

trial in Endocarditis. Withdrawn.

Quick facts

Lead sponsor	Virginia Commonwealth University
Status	Withdrawn
Study type	OBSERVATIONAL
Sites	1 location across United States

Conditions studied

Endocarditis — all drugs for Endocarditis →

Sponsor

Virginia Commonwealth University

Who can join

18 and older, any sex, with Endocarditis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This is an analysis of the outcomes of patients having undergone surgical intervention for infective endocarditis.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Endocarditis

Currently open trials in the same condition.

NCT05139589 — The ENDOCARDITIS AUMC Data Collection · recruiting
NCT05547607 — Clinical and Diagnostic Features of Endocarditis · recruiting
NCT05146180 — Interest of Parametric Positron Emission Imaging in the Diagnosis of Infections on Cardiac Valve Prosthesis · NA · recruiting
NCT06403839 — Impact of Preoperative Dental Screening in Reducing Infective Endocarditis Risk in Surgical Valve Replacement Patients · recruiting
NCT03892174 — Cytokine REmoval in CRitically Ill PAtients Requiring Surgical Therapy for Infective Endocarditis (RECReATE) · NA · recruiting

Other Virginia Commonwealth University trials

Trials by the same sponsor.

NCT05936931 — Young Adult-Mediated Intervention to Increase Colorectal Cancer Screening · NA · not yet recruiting
NCT07365839 — Cemiplimab +/- Fianlimab Post Y90 Radioembolization in Patients With Hepatocellular Carcinoma · Phase 1 · not yet recruiting
NCT07178158 — Enhancing Addiction Treatment Through Psychoeducation · NA · not yet recruiting
NCT07531316 — Safety and Tolerability Study of VVZ-2471 in Healthy Volunteers · Phase 1 · not yet recruiting
NCT07426913 — Cardiovascular Health Education Via Virtual Reality for Breast Cancer Survivors Receiving Anthracyclines or Trastuzumab · NA · not yet recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT00579761 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Virginia Commonwealth University
Last refreshed: 14 December 2015

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00579761.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing